NCOA3 and breast carcinoma: For example, overexpression or amplification of the steroid receptor coactivator-3 (SRC-3/NCOA-3/AIB1) has been associated with enhancement of ERα ligand-independent transactivation and poor prognosis in ERα positive breast cancer (20, 21, 22, 23).